Logo

Application of log-normal parametric model in disability structure to predict metastasis and death due to breast cancer

Author(s):
Morteza HajihosseiniMorteza Hajihosseini, Payam AminiPayam Amini, Maryam ShahdoustMaryam Shahdoust, Javad  FaradmalJavad Faradmal,*, Majid SadeghyfarMajid Sadeghyfar, Abdolazim Sedighi-PashakiAbdolazim Sedighi-Pashaki

Koomesh:Vol. 18, issue 1; 95-101
Published online:Sep 28, 2016
Article type:Research Article
Received:Dec 06, 2015
Accepted:May 01, 2016
How to Cite:Morteza HajihosseiniPayam AminiMaryam ShahdoustJavad FaradmalMajid SadeghyfarAbdolazim Sedighi-Pashakiet al.Application of log-normal parametric model in disability structure to predict metastasis and death due to breast cancer.koomesh.18(1):e151150.

Abstract

References

  • 1.
    Huang Y. Censored regression with the multistate accelerated sojourn times model. J R Stat Soc Series B Stat Methodol 2002; 64: 17-29.
  • 2.
    Putter H, van der Hage J, de Bock GH, Elgalta R, van de Velde CJ. Estimation and Prediction in a MultiState Model for Breast Cancer. Biom J 2006; 48: 366-380.
  • 3.
    Jafari-Koshki T, Schmid VJ, Mahaki B. Trends of breast cancer incidence in Iran during 20042008: a Bayesian space-time model. Asian Pac J Cancer Prev 2014; 15: 1557-1561.
  • 4.
    Gohari MR, Fard Z, Abolghasemi J, Mohammadi M, Mokhtari P. Prognostic factors of metastases in breast cancer patients using the recurrent Andersen-Gill model. Koomesh 2013; 14: 483-489 (Persian).
  • 5.
    Yaghmaei S, BANI HG, GHORBANI R. Survival rate following treatment of primary breast cancer in Semnan, Iran (1991-2002). Koomesh 2008; 9: 111-116. (Persian).
  • 6.
    Faradmal J, Kazemnejad A, Bakhshi R, Hajizadeh E, Gohari MR. Comparing three adjuvant chemotherapy regimes after modified radical mastectomy in breast cancer patients using log-logistic model. Koomesh 2010; 11: Pe279-Pe87 (Persian).
  • 7.
    Akbari ME, Mozaffar M, Heidari A, Zirakzadeh H, Akbari A, Akbari M, Shirazi FH. Recurrence and survival effect in breast conserving surgery: what are the predictive and/or prognostic factors? Iran J Cancer Prev 2011; 4: 49-54.
  • 8.
    Lee ET, Wang JW. Statistical methods for survival data analysis. 4th ed. New York: John Wiley & Sons; 2013.
  • 9.
    Meier-Hirmer C, Schumacher M. Multi-state model for studying an intermediate event using time-dependent covariates: application to breast cancer. BMC Med Res Methodol 2013; 13: 80.
  • 10.
    Hougaard P. Multi-state models: a review. Lifetime Data Anal 1999; 5: 239-64.
  • 11.
    Andersen PK. Multistate models in survival analysis: a study of nephropathy and mortality in diabetes. Stat Med 1988; 7: 661-670.
  • 12.
    Bhattacharyya M, Klein JP. A random effects model for multistate survival analysis with application to bone marrow transplants. Math Biosci 2005; 194: 37-48.
  • 13.
    Frydman H, Szarek M. Estimation of overall survival in an illnessdeathmodel with application to the vertical transmission of HIV1. Stat Med 2010; 29: 2045-2054.
  • 14.
    Putter H, Fiocco M, Geskus R. Tutorial in biostatistics: competing risks and multistate models. Stat Med 2007; 26: 2389-2430.
  • 15.
    Tsuji W, Teramukai S, Ueno M, Toi M, Inamoto T. Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution. Breast Cancer 2014; 21: 86-95.
  • 16.
    Egner JR. AJCC cancer staging manual. JAMA 2010; 304: 1726-1727.
  • 17.
    Faradmal J, Mafi M, Sadighi-Pashaki A, Karami M, Roshanaei G. Factors Affecting Survival in Breast Cancer Patients Referred to the Darol Aitam-e Mahdieh Center. ZUMS J 2014; 22: 105-115 (Persian).
  • 18.
    Agresti A. Categorical data analysis. 3rd ed. New York: John Wiley & Sons; 2014.
  • 19.
    R Core Team. R: A language and environment for statistical computing. vienna, austria: R foundation for statistical computing; 2014.
  • 20.
    Royston P. The lognormal distribution as a model for survival time in cancer, with an emphasis on prognostic factors. Stat Neerl 2001; 55: 89-104.
  • 21.
    Kim M-J, Ro JY, Ahn S-H, Kim HH, Kim S-B, Gong G. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol 2006; 37: 1217-1226.
  • 22.
    Xue C, Wang X, Peng R, Shi Y, Qin T, Liu D, et al. Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China. Cancer Sci 2012; 103: 1679-1687.
  • 23.
    Society AC. Breast cancer facts and figures 20112012. Am Cancer Society Atlanta GA; 2011.
  • 24.
    Gao N, Xu H, Liu C, Xu H, Chen G, Wang X, Li Y, Wang Y. Nestin: predicting specific survival factors for breast cancer. Tumour Biol 2014; 35: 1751-1755.
  • 25.
    Fallahzadeh H, Momayyezi M, Akhundzardeini R, Zarezardeini S. Five year survival of women with breast cancer in Yazd. Asian Pac J Cancer Prev 2014; 15: 6597-6601.
  • 26.
    de Bock GH, Putter H, Bonnema J, van der Hage JA, Bartelink H, van de Velde CJ. The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model. Breast Cancer Res Trea 2009; 117: 401-408.##.
comments

Leave a comment here

Share on
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles